Humanin is a mitochondria-derived peptide (MDP) composed of 24 amino acids, first discovered within the mitochondrial genome. It is best known for its protective role against cellular stress, apoptosis, and age-related decline. Humanin interacts with multiple receptors, including the formyl peptide receptor-like 1 (FPRL1), to exert cytoprotective and metabolic regulatory effects.
In research settings, Humanin has been widely studied for its impact on mitochondrial function, energy metabolism, neuroprotection, and longevity pathways. It has also shown promise in modulating insulin sensitivity, reducing oxidative damage, and supporting cardiovascular health, making it of growing interest in aging and metabolic research.
Potential applications of Humanin peptide research include:
Where it is being applied in research
- Neuroprotection and cognitive support through mitochondrial and anti-apoptotic pathways
- Anti-aging and longevity studies via cellular stress resistance and survival signaling
- Metabolic health research including improved insulin sensitivity and glucose regulation
- Cardiovascular protection through reduction of oxidative stress and vascular support Humanin remains a focus of ongoing research in mitochondrial biology, aging sciences, metabolic health, and neurodegenerative disease studies. HUMANIN COA
Summary of published preclinical and clinical literature, provided for research context only. Not a claim of efficacy and not medical advice.
